Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Vaccine for Early-Stage Renal Cell Carcinoma Shows Promise
Link ID 4417
Title Vaccine for Early-Stage Renal Cell Carcinoma Shows Promise
Url http://www.medscape.com/viewarticle/572225?src=rss
Description When used long term, the autologous vaccine vitespen shows promise for adjuvant treatment of early-stage disease in patients with renal cell carcinoma. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. FLT-PET Imaging Superior to Bone-Marrow Biopsy for Assessing Treatment Response in Leukemia
  FLT-PET imaging may be able to determine treatment response among adult leukemia patients after only 1 day of chemotherapy, which can improve disease management and spare patients from ineffective chemotherapy Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Gemcitabine-Based Combination Chemotherapy Ups Survival in Pancreatic Cancer
  Gemcitabine, in combination with platinum analogs or fluoropyrimidines, improves survival in patients with advanced pancreatic cancer, according to results of a meta-analysis reported in the March 28th issue of BMC Cancer. Reuters Health Information
Category:   Articles > Hematology-Oncology


3. Management of Nerve Sheath Tumors Arising in the Sympathetic Chain
  Extradural schwannomas are uncommon and can present management challenges. Three case studies are reviewed to detail specific management practices for cervical, thoracic, and lumbar lesions.
Cancer Control: Journal of the Moffitt Cancer Center
Category:   Articles > Hematology-Oncology


4. The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment an
  Outline issues and complications related to paroxysmal nocturnal hemoglobinuria (PNH), and review current and emerging treatment regimens for patients with PNH.
Category:   Articles > Hematology-Oncology


5. Survival Benefit with Low-Dose Dexamethasone in Multiple Myeloma
  Using low-dose dexamethasone with lenalinomide instead of high-dose dexamethasone in newly diagnosed multiple myeloma patients confers a significant survival advantage and has less toxicity. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS